PL318017A1 - Peptides - Google Patents

Peptides

Info

Publication number
PL318017A1
PL318017A1 PL95318017A PL31801795A PL318017A1 PL 318017 A1 PL318017 A1 PL 318017A1 PL 95318017 A PL95318017 A PL 95318017A PL 31801795 A PL31801795 A PL 31801795A PL 318017 A1 PL318017 A1 PL 318017A1
Authority
PL
Poland
Prior art keywords
peptides
Prior art date
Application number
PL95318017A
Inventor
Francois Cardinaux
Jean Honore M Feyen
Rainer Gamse
Frank Otto Gombert
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9415255A external-priority patent/GB9415255D0/en
Priority claimed from GB9415254A external-priority patent/GB9415254D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of PL318017A1 publication Critical patent/PL318017A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL95318017A 1994-07-28 1995-07-27 Peptides PL318017A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9415255A GB9415255D0 (en) 1994-07-28 1994-07-28 Organic compounds
GB9415254A GB9415254D0 (en) 1994-07-28 1994-07-28 Organic compounds
PCT/EP1995/002993 WO1996003437A1 (en) 1994-07-28 1995-07-27 PTH OR PTHrP ANTAGONISTS

Publications (1)

Publication Number Publication Date
PL318017A1 true PL318017A1 (en) 1997-05-12

Family

ID=26305357

Family Applications (1)

Application Number Title Priority Date Filing Date
PL95318017A PL318017A1 (en) 1994-07-28 1995-07-27 Peptides

Country Status (15)

Country Link
EP (1) EP0773958A1 (en)
JP (1) JPH10502091A (en)
AU (1) AU3167095A (en)
BR (1) BR9508433A (en)
CA (1) CA2192787A1 (en)
CO (1) CO4410206A1 (en)
CZ (1) CZ23397A3 (en)
FI (1) FI970168A (en)
HU (1) HUT77979A (en)
IL (1) IL114736A0 (en)
NO (1) NO970356D0 (en)
PL (1) PL318017A1 (en)
SK (1) SK12097A3 (en)
TR (1) TR199500915A2 (en)
WO (1) WO1996003437A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW505654B (en) * 1996-07-30 2002-10-11 Hoffmann La Roche Synthesis of analogs of PTH and PTHrP
DE69734157T2 (en) 1996-07-31 2006-07-13 The General Hospital Corp., Boston PARATHYROIDHORMONE-RELATED PEPTIDE ANALOG
IL129164A (en) 1996-09-26 2007-05-15 Chugai Pharmaceutical Co Ltd Antibody against human parathormone related peptides
CA2290443A1 (en) 1997-05-14 1998-11-19 Rhone-Poulenc Rorer Pharmaceuticals Inc. Peptide parathyroid hormone analogs
ES2285769T3 (en) 1997-05-15 2007-11-16 Chugai Seiyaku Kabushiki Kaisha REMEDY FOR CAQUEXY.
TWI255718B (en) 1999-07-02 2006-06-01 Chugai Pharmaceutical Co Ltd Ameliorative agent for low vasopressin concentration
WO2001002011A1 (en) * 1999-07-02 2001-01-11 Chugai Seiyaku Kabushiki Kaisha REMEDIES FOR DISEASES CAUSED BY PTH OR PTHrP
BR0012467A (en) * 1999-07-06 2002-06-11 Chugai Pharmaceutical Co Ltd Therapeutic agent for drug-resistant hypercalcemia
EP1221966B1 (en) * 1999-09-20 2005-11-16 Eli Lilly And Company Use of a parathyroid hormone for reducing the risk of cancer
US20030049211A1 (en) * 2000-01-25 2003-03-13 Atsuhiko Kato Remedies and preventives for dental diseases
CA2401357A1 (en) * 2000-02-28 2001-09-07 Chugai Seiyaku Kabushiki Kaisha Tissue degradation inhibitor agent
JP4846169B2 (en) 2000-04-28 2011-12-28 中外製薬株式会社 Cell growth inhibitor
EP1849479A1 (en) * 2000-08-16 2007-10-31 Chugai Seiyaku Kabushiki Kaisha Ameliorating agent for symptoms resulting from joint diseases
BRPI0814962B8 (en) 2007-08-01 2021-05-25 Chugai Pharmaceutical Co Ltd in vitro methods to determine whether a candidate compound is a long-acting or short-acting agonist of a g protein-coupled receptor, polypeptide, its use and pharmaceutical composition
EP2569003B1 (en) 2010-05-13 2017-10-25 The General Hospital Corporation Parathyroid hormone analogs and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2040264A1 (en) * 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
CA2087190A1 (en) * 1990-07-13 1992-01-14 Fred E. Cohen Parathyroid hormone analogues modified at positions
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments

Also Published As

Publication number Publication date
NO970356L (en) 1997-01-28
BR9508433A (en) 1998-07-14
HUT77979A (en) 1999-01-28
MX9700446A (en) 1998-06-28
TR199500915A2 (en) 1996-06-21
FI970168A0 (en) 1997-01-15
FI970168A (en) 1997-01-15
AU3167095A (en) 1996-02-22
CO4410206A1 (en) 1997-01-09
JPH10502091A (en) 1998-02-24
WO1996003437A1 (en) 1996-02-08
SK12097A3 (en) 1997-08-06
EP0773958A1 (en) 1997-05-21
CZ23397A3 (en) 1997-07-16
IL114736A0 (en) 1995-11-27
NO970356D0 (en) 1997-01-28
CA2192787A1 (en) 1996-02-08

Similar Documents

Publication Publication Date Title
EP0765165A4 (en) Constrained peptides
IL108169A0 (en) New peptides
PL318017A1 (en) Peptides
GB9500601D0 (en) Modified peptides
AU2131195A (en) Prophenins - antibiotic peptides
EP0746565A4 (en) Novel bombesin-related peptides
GB9718110D0 (en) Peptides
HUP9603537A2 (en) Peptides having immunmodulator influences
GB9425380D0 (en) Peptides
IL115317A0 (en) Proteins
GB9700154D0 (en) Peptides
EP0996457A4 (en) Fsh-releasing peptides
AUPM489194A0 (en) Peptides
GB9519511D0 (en) Peptides
GB9425381D0 (en) Peptides
GB9613705D0 (en) Novel peptides
ZA956331B (en) Peptides
GB9421408D0 (en) Peptides
GB9411049D0 (en) Peptide
GB9625227D0 (en) Peptides
GB9608430D0 (en) Peptides
SG55039A1 (en) Peptides
GB9606765D0 (en) Peptides
GB9612648D0 (en) Peptides
GB9626362D0 (en) Peptides